Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9182414 | Methods for identifying a GLP-1 secretagogue | James N. Leonard | 2015-11-10 |
| 8883714 | Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues | James N. Leonard, Robert M. Jones | 2014-11-11 |
| 8580526 | Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion | James N. Leonard | 2013-11-12 |
| 8486646 | Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues | James N. Leonard, Robert M. Jones | 2013-07-16 |
| 8354241 | Methods for identifying a GLP-1 secretagogue | James N. Leonard | 2013-01-15 |
| 8198232 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | James N. Leonard, Hussien Al-Shamma, Robert M. Jones | 2012-06-12 |
| 8101626 | GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto | James N. Leonard, Juerg Lehmann, Robert M. Jones | 2012-01-24 |
| 8039219 | Method of using GPR35 to identify metabolic-stabilizing compounds | James N. Leonard | 2011-10-18 |
| 8030270 | Methods for identifying GLP-1 secretagogues | James N. Leonard, Hussien Al-Shamma, Robert M. Jones | 2011-10-04 |
| 8026074 | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual | James N. Leonard | 2011-09-27 |
| 8026212 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues | James N. Leonard | 2011-09-27 |
| 8022034 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | James N. Leonard, Hussien Al-Shamma, Robert M. Jones | 2011-09-20 |
| 8017574 | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues | James N. Leonard | 2011-09-13 |
| 8003597 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | James N. Leonard, Hussein A. Al-Shamma, Robert M. Jones | 2011-08-23 |
| 7838254 | Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY | James N. Leonard, Robert M. Jones | 2010-11-23 |
| 7833730 | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual | James N. Leonard | 2010-11-16 |
| 7816364 | GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto | James N. Leonard, Juerg Lehmann, Robert M. Jones | 2010-10-19 |
| 7803754 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | James N. Leonard, Hussien Al-Shamma, Robert M. Jones | 2010-09-28 |
| 7803753 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | James N. Leonard, Hussien Al-Shamma, Robert M. Jones | 2010-09-28 |
| 6953691 | Nucleic acid molecule encoding a PANG6 polypeptide | John C. Reed, Adam Godzik, Krzysztof Pawlowski, Loredana Fiorentino, Maria Eugenia Ariza +1 more | 2005-10-11 |